MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-12-2024
Cutera Market Cap 2011-2026 | CUTR
As of March 19, 2026 Cutera has a market cap of $ 1.99 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Cutera
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 46.5 M | 442 M | 686 M | 590 M | 409 M | 194 M | 687 M | 243 M | 157 M | 190 M | 139 M | 153 M | 108 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 687 M | 46.5 M | 311 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
3.03 M | $ 2.24 | 0.9 % | $ 3.5 M |  USA |
 |
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | USA |
 |
AdaptHealth Corp.
AHCO
|
1.2 B | $ 10.47 | 0.19 % | $ 1.41 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | USA |
 |
Alphatec Holdings
ATEC
|
2.07 B | $ 12.56 | -3.75 % | $ 1.88 B | USA |
 |
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | USA |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
316 M | $ 9.61 | -13.93 % | $ 272 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
661 M | $ 8.37 | 0.12 % | $ 601 M |  Israel |
 |
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Butterfly Network
BFLY
|
766 M | $ 3.95 | -7.49 % | $ 836 M | USA |
 |
Cytosorbents Corporation
CTSO
|
54.4 M | $ 0.65 | -4.41 % | $ 35.4 M | USA |
 |
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | USA |
 |
Boston Scientific Corporation
BSX
|
113 B | $ 71.28 | 0.11 % | $ 106 B | USA |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
60 M | $ 3.92 | -3.21 % | $ 146 M |  France |
 |
CONMED Corporation
CNMD
|
1.32 B | $ 36.71 | -1.69 % | $ 1.14 B | USA |
 |
Establishment Labs Holdings
ESTA
|
2.31 B | $ 65.5 | 0.75 % | $ 1.94 B |  Costa-rica |
 |
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | USA |
 |
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | USA |
 |
GBS
GBS
|
2.48 M | - | -0.57 % | $ 7.12 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
677 M | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
85.2 M | $ 18.44 | -0.05 % | $ 121 M | USA |
 |
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | USA |
 |
InMode Ltd.
INMD
|
928 M | $ 13.45 | -1.47 % | $ 869 M | Israel |
 |
Abbott Laboratories
ABT
|
196 B | $ 108.49 | -2.04 % | $ 189 B | USA |
 |
Delcath Systems
DCTH
|
326 M | $ 9.38 | -3.7 % | $ 336 M | USA |
 |
Bio-Rad Laboratories
BIO
|
7.81 B | $ 267.99 | -0.55 % | $ 7.56 B | USA |
 |
Helius Medical Technologies
HSDT
|
3.54 M | $ 2.07 | -4.61 % | $ 1.26 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
1.88 B | $ 8.9 | -2.2 % | $ 685 M | USA |
 |
IRIDEX Corporation
IRIX
|
48.1 M | $ 1.33 | - | $ 21.5 M | USA |
 |
AxoGen
AXGN
|
1.5 B | $ 30.94 | -5.53 % | $ 1.42 B | USA |
 |
Align Technology
ALGN
|
13.9 B | $ 172.41 | -2.11 % | $ 12.9 B | USA |
 |
Bruker Corporation
BRKR
|
6.9 K | $ 34.03 | 0.86 % | $ 5.07 K | USA |
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
142 M | $ 3.67 | -1.87 % | $ 151 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
437 M | $ 16.66 | -3.2 % | $ 391 M | USA |
 |
Second Sight Medical Products
EYES
|
225 K | - | -0.97 % | $ 54.4 M | USA |
 |
Accuray Incorporated
ARAY
|
160 M | $ 0.41 | 5.24 % | $ 42.1 M | USA |
 |
IRadimed Corporation
IRMD
|
1.25 B | $ 99.67 | -3.04 % | $ 1.27 B | USA |